376 related articles for article (PubMed ID: 29476781)
1. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
[TBL] [Abstract][Full Text] [Related]
2. Quantitative dynamic contrast-enhanced MR imaging for the preliminary prediction of the response to gemcitabine-based chemotherapy in advanced pancreatic ductal carcinoma.
Tang W; Liu W; Li HM; Wang QF; Fu CX; Wang XH; Zhou LP; Peng WJ
Eur J Radiol; 2019 Dec; 121():108734. PubMed ID: 31743881
[TBL] [Abstract][Full Text] [Related]
3. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameters in Rectal Cancer.
Sun H; Xu Y; Xu Q; Duan J; Zhang H; Liu T; Li L; Chan Q; Xie S; Wang W
Acad Radiol; 2019 Jul; 26(7):e134-e140. PubMed ID: 30268719
[TBL] [Abstract][Full Text] [Related]
5. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
[TBL] [Abstract][Full Text] [Related]
6. Six-dimensional quantitative DCE MR Multitasking of the entire abdomen: Method and application to pancreatic ductal adenocarcinoma.
Wang N; Gaddam S; Wang L; Xie Y; Fan Z; Yang W; Tuli R; Lo S; Hendifar A; Pandol S; Christodoulou AG; Li D
Magn Reson Med; 2020 Aug; 84(2):928-948. PubMed ID: 31961967
[TBL] [Abstract][Full Text] [Related]
7. Accurate Therapeutic Response Assessment of Pancreatic Ductal Adenocarcinoma Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging With a Point-of-Care Perfusion Phantom: A Pilot Study.
Kim H; Morgan DE; Schexnailder P; Navari RM; Williams GR; Bart Rose J; Li Y; Paluri R
Invest Radiol; 2019 Jan; 54(1):16-22. PubMed ID: 30138218
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
11. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.
Xian J; Du H; Wang X; Yan F; Zhang Z; Hao H; Zhao B; Tong Y; Zhang J; Han D
Chin Med J (Engl); 2014; 127(12):2259-64. PubMed ID: 24931238
[TBL] [Abstract][Full Text] [Related]
13. Intravoxel Incoherent Motion Combined With Dynamic Contrast-Enhanced Perfusion MRI of Early Cervical Carcinoma: Correlations Between Multimodal Parameters and HIF-1α Expression.
Li X; Wu S; Li D; Yu T; Zhu H; Song Y; Meng L; Fan H; Xie L
J Magn Reson Imaging; 2019 Sep; 50(3):918-929. PubMed ID: 30648775
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for pretreatment prediction of neoadjuvant chemotherapy response in locally advanced hypopharyngeal cancer.
Guo W; Zhang Y; Luo D; Yuan H
Br J Radiol; 2020 Nov; 93(1115):20200751. PubMed ID: 32915647
[No Abstract] [Full Text] [Related]
15. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Orthotopic Mouse Model of Pancreatic Cancer.
Cao J; Pickup S; Rosen M; Zhou R
Mol Imaging Biol; 2023 Aug; 25(4):638-647. PubMed ID: 37166575
[TBL] [Abstract][Full Text] [Related]
16. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MRI of nasopharyngeal carcinoma: a preliminary study of the correlations between quantitative parameters and clinical stage.
Zheng D; Chen Y; Chen Y; Xu L; Chen W; Yao Y; Du Z; Deng X; Chan Q
J Magn Reson Imaging; 2014 Apr; 39(4):940-8. PubMed ID: 24108569
[TBL] [Abstract][Full Text] [Related]
18. Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Pancreatic Cancer: Characteristics and Correlation With Histopathologic Parameters.
Ma W; Li N; Zhao W; Ren J; Wei M; Yang Y; Wang Y; Fu X; Zhang Z; Larson AC; Huan Y
J Comput Assist Tomogr; 2016; 40(5):709-16. PubMed ID: 27224231
[TBL] [Abstract][Full Text] [Related]
19. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
20. Dependence of DCE-MRI biomarker values on analysis algorithm.
Ng CS; Wei W; Bankson JA; Ravoori MK; Han L; Brammer DW; Klumpp S; Waterton JC; Jackson EF
PLoS One; 2015; 10(7):e0130168. PubMed ID: 26208254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
